The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of GVD and anti-PD-1 (SHR-1210) regimen with or without low-dose decitabine priming for refractory bulky and aggressive primary mediastinal large B-cell lymphoma.
 
Wenying Zhang
No Relationships to Disclose
 
Yang Liu
No Relationships to Disclose
 
Qian Mei
No Relationships to Disclose
 
Lianjun Shen
No Relationships to Disclose
 
Qingming Yang
No Relationships to Disclose
 
WeiDong Han
No Relationships to Disclose